Allograft and xenograft rejection in C3H/SCID mice: A new model for the study of non-T cell graft rejection mechanisms

Transplantation

Volumn 61, Issue 5, 1996, Pages 777-783

  Marcus, Hadar ^a   Factorovich, Yfat ^a   Kulova, Lydia ^b   Denes, Laszlo ^a   Segal, Harry ^a   David, Magda ^a   Burakova, Tanya ^a   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN TRANSPLANTATION; XENOGRAFT;

ANIMALS; BONE MARROW TRANSPLANTATION; BURKITT LYMPHOMA; GRAFT REJECTION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, SCID; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029979609     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603150-00018     Document Type: Article

References (27)

1. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev 1989; 1: 273.
2. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; ii: 1366.
3. O'Reilly RJ, Kapoor N, Kirkpatrick D, et al. Transplantation of hematopoietic cells for lethal congenital immunodeficiencies. In: Wedgwood RJ, Rosen FS, Paul NW, eds. Primary immunodeficiency diseases - Birth defects: Original article series. New York: Alan R. Liss, Inc., 1983: 129.
4. Fischer A, Friedrich W, Levinsky R, Vossen J, Criscelli Cea. Bone marrow transplantation for immunodeficiencies and osteoporosis: European survey 1968-1985. Lancet 1986; ii: 1080.
5. Lenarsky T, Parkman R. Bone marrow transplantation for the treatment of immune deficiency states. Bone Marrow Transplant 1990; 6: 361.
6. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for acute leukaemia with HLA-A and B non-identical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet 1981; ii: 327.
7. Fischer A. Severe combined immunodeficiencies. Immunodefic Rev 1992; 3: 83.
8. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527.
9. Malynn B, Blackwell T, Fulop G, et al. The SCID defect affects the final step of the immunoglobulin VDJ recombinase mechanism. Cell 1988; 54: 453.
10. Mosier DE, Gulizia RJ, Torbett BE, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256.
11. Carlsson R, Martensson C, Kalliomaki S, Ohlin M, Borrebaeck CA. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies. J Immunol 1992; 148: 1065.
12. Nonoyama S, Smith FO, Bernstein ID, Ochs HD. Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 1993; 150: 3817.
13. Pollock P, Germolec D, Comment C, Rosenthal G, Luster M. Development of human lymphocyte-engrafted SCID mice as a model for immunotoxicity assessment. Fundam Appl Toxicol 1994; 22: 130.
14. Lubin I, Segall H, Marcus H, et al. Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood 1994; 83: 2368.
15. Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hematopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci USA 1978; 75: 2933.
16. Schwartz E, Lapidot T, Gozes D, Singer TS, Reisner Y. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T-cells and alloreactive cytotoxic precursors. J Immunol 1987; 138: 460.
17. Wangenheim KH, Siegers MP, Feinendegen LE. Repopulation ability and proliferation stimulus in the hematopoietic system of mice following gamma-irradiation. Exp Hematol 1980; 8: 694.
18. Baharav E, Lider O, Margalit M, Cohen IR. A modified technique for experimental skin grafting. J Immunol Methods 1986; 90: 143.
19. Ott L. An introduction to statistical methods and data analysis. Boston: Pws-Kent Publishing Company, 1988: 239.
20. Bosma G, Fried M, Custer R, Carroll A, Gibson D, Bosma M. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med 1988; 167: 1016.
21. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187.
22. Kiessling R, Hochman P, Haller O, Shearer G, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977; 7: 655.
23. Yu Y, Kumar V, Bennett M. Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 1992; 10: 189.
24. Rolstad B, Wonigeit K, Vaage J. Alloreactive rat natural killer (NK) cells in vivo and in vitro: the role of the major histocompatibility complex (MHC). In: Rolstad B, ed. Natural immunity to normal hematopoietic cells. Boca Raton, FL: CRC Press, Inc., 1994: 99.
25. Murphy W, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987; 165: 1212.
26. Pollack M, Kapoor N, Sorell M, Morishima Y, Dupont B, O'Reilly R. Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells. Transplant Proc 1981; 13: 270.
27. Markert M, Buckley R. Natural-killer-cell function and bone marrow transplantation. N Engl J Med 1986; 315: 1418.